AGC Biologics Manufactures Key Ingredient in Potential COVID-19 Treatment Drug, Leronlimab

The drug, Leronlimab, owned by CytoDyn, containing a special molecule manufactured by AGC Biologics, is showing favorable results in the treatment of severely affected COVID-19 patients.  AGC Biologics stands ready to ramp up manufacturing to meet demand once this drug is FDA approved.

HubSpot Video


Topics: News
Follow Us
Join us on LinkedIn Follow us on Twitter